See more : Avila Energy Corporation (VIK.CN) Income Statement Analysis – Financial Results
Complete financial analysis of iTeos Therapeutics, Inc. (ITOS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of iTeos Therapeutics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Turn Cloud Technology Service Inc. (6870.TWO) Income Statement Analysis – Financial Results
- Signal Gold Inc. (ANX.TO) Income Statement Analysis – Financial Results
- Maxar Technologies Inc. (MAXR) Income Statement Analysis – Financial Results
- Mandarin Oriental International Limited (MDO.L) Income Statement Analysis – Financial Results
- City Online Services Limited (CITYONLINE.BO) Income Statement Analysis – Financial Results
iTeos Therapeutics, Inc. (ITOS)
About iTeos Therapeutics, Inc.
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.60M | 267.63M | 344.78M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 898.00K | 813.00K | 615.00K | 535.00K | 611.00K | 505.00K |
| Gross Profit | 11.70M | 266.82M | 344.16M | -535.00K | -611.00K | -505.00K |
| Gross Profit Ratio | 92.87% | 99.70% | 99.82% | 0.00% | 0.00% | 0.00% |
| Research & Development | 113.30M | 97.36M | 59.37M | 29.90M | 19.21M | 17.19M |
| General & Administrative | 50.40M | 43.95M | 40.51M | 15.34M | 8.84M | 4.31M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 50.40M | 43.95M | 40.51M | 15.34M | 8.84M | 4.31M |
| Other Expenses | 0.00 | -3.26M | -10.18M | -5.93M | -4.78M | -163.00K |
| Operating Expenses | 163.70M | 138.04M | 89.69M | 39.31M | 23.27M | 17.82M |
| Cost & Expenses | 163.70M | 138.04M | 89.69M | 39.31M | 23.27M | 17.82M |
| Interest Income | 31.77M | 11.36M | 78.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 66.00K |
| Depreciation & Amortization | 898.00K | 813.00K | 615.00K | 535.00K | 611.00K | 505.00K |
| EBITDA | -151.10M | 148.38M | 257.08M | -37.84M | -21.72M | -17.48M |
| EBITDA Ratio | -1,199.69% | 48.72% | 74.16% | 0.00% | 0.00% | 0.00% |
| Operating Income | -151.10M | 126.32M | 244.90M | -45.24M | -28.05M | -21.50M |
| Operating Income Ratio | -1,199.69% | 47.20% | 71.03% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 42.07M | 22.41M | 11.56M | 7.15M | 5.71M | 3.46M |
| Income Before Tax | -109.03M | 148.74M | 256.46M | -38.09M | -22.34M | -18.05M |
| Income Before Tax Ratio | -865.66% | 55.58% | 74.39% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 3.61M | 52.08M | 41.94M | -57.00K | 119.00K | 11.00K |
| Net Income | -112.64M | 96.65M | 214.52M | -38.03M | -22.45M | -18.06M |
| Net Income Ratio | -894.34% | 36.11% | 62.22% | 0.00% | 0.00% | 0.00% |
| EPS | -3.15 | 2.72 | 6.10 | -1.09 | -0.64 | -2.40 |
| EPS Diluted | -3.15 | 2.56 | 5.68 | -1.09 | -0.64 | -2.40 |
| Weighted Avg Shares Out | 35.76M | 35.55M | 35.18M | 35.04M | 35.02M | 7.51M |
| Weighted Avg Shares Out (Dil) | 35.76M | 37.77M | 37.77M | 35.04M | 35.02M | 7.51M |
iTeos to Present at the 39th Annual J.P. Morgan Healthcare Conference
Eos Energy Storage Announces Additional Contract with Carson Hybrid Energy Storage
Canon Announces Powerful New EL-1 Speedlite with Rechargeable Battery and EOS M50 Mark II Mirrorless Digital Camera; More Info at B&H
Babcock & Wilcox Renewable Announces Global Partnership for Battery Solutions with Eos Energy Storage
3D Printer Market | Demand for 3D Customized Products to Boost the Market Growth | Technavio
EOS Climbs 10% In a Green Day
EOS's Top Block Producer Has Endorsed "One Token, One Vote" | Crypto Briefing
Source: https://incomestatements.info
Category: Stock Reports